Subscribe to RSS
Download PDF
DOI: 10.1055/s-0043-1761264
The “Blast” Behind Jerky Eyes
Authors
Funding None.
Abstract
Opsoclonus is defined as hyperkinetic, omnidirectional, spontaneous, and involuntary chaotic eye movements. Opsoclonus-myoclonus-ataxia syndrome is addressed by many names including “dancing eyes-dancing feet syndrome,” “Kinsbourne syndrome,” and “infantile polymyoclonia.” The early accounts of the clinical syndrome date back to 1962 when Marcel Kinsbourne described six cases of this phenotype. However, it was not until 1968 the association with occult neuroblastoma was first reported. We report the video of a 1-year-old boy who presented with this syndrome for a duration of 3 months. He was diagnosed to have an abdominal neuroblastoma and was treated with resection of the tumor and administration of intramuscular adrenocorticotropic hormone. He showed complete resolution of symptoms. The syndrome is difficult to recognize and might be confused with seizures, tremors, or chorea; hence, it is important that residents learnt to recognize this syndrome and look for an underlying tumor actively.
Publication History
Article published online:
12 May 2023
© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Goraya JS. Acute movement disorders in children: experience from a developing country. J Child Neurol 2015; 30 (04) 406-411
- 2 Neurological sequelae of the dancing eye syndrome - PubMed [Internet]. [cited 2021 Mar 19]. Accessed January 8, 2023, at: https://pubmed.ncbi.nlm.nih.gov/8929735/
- 3 Sahu JK, Prasad K. The opsoclonus–myoclonus syndrome. Pract Neurol 2011; 11 (03) 160-166
- 4 Galstyan A, Wilbur C, Selby K, Hukin J. Opsoclonus-myoclonus syndrome: a new era of improved prognosis?. Pediatr Neurol 2017; 72: 65-69
- 5 Pranzatelli MR. The neurobiology of the opsoclonus-myoclonus syndrome. Clin Neuropharmacol 1992; 15 (03) 186-228
- 6 Pranzatelli MR, Tate ED, McGee NR. Demographic, clinical, and immunologic features of 389 children with opsoclonus-myoclonus syndrome: a cross-sectional study. Front Neurol 2017; 8: 468 https://www.frontiersin.org/articles/10.3389/fneur.2017.00468 cited 2022Oct26 [Internet]
- 7 Rossor T, Yeh EA, Khakoo Y. et al; OMS Study Group. Diagnosis and management of opsoclonus-myoclonus-ataxia syndrome in children: an international perspective. Neurol Neuroimmunol Neuroinflamm 2022; 9 (03) e1153